Clintec International ranks 84th in The Sunday Times HSBC International Track 200

Posted On

Clintec ranks 84th out of the 200 companies in The Sunday Times HSBC International Track 200 league table.  The table ranks Britain’s fastest-growing mid-market private companies in order of fastest growing international sales, published in The Sunday Times on 10th June 2018. The Track 200 recognises Clintec’s entrepreneurial success and forward-thinking vision to overcome the obstacles international diversification brings, such as expanding into differentiated markets such as Sub-Saharan Africa.

Clintec Finance team will celebrate businesses that are taking the best of Britain to markets across the globe at The Sunday Times HSBC International Track 200 Awards dinner in London on 11th September. This award recognises Clintec’s entrepreneurship to explore new routes to growth, and overcome the challenges and strong competition with embracing international opportunities. Through resilience and determination, Clintec continues to expand into new, international markets.

Clintec is an established and renowned Clinical Research Organisation, having grown organically in over 50 countries including both developed and emerging markets, and champions its diversity in its international business. As a certified member of the WEConnect network (Women owned business in the UK), Clintec is proud to demonstrate diversity and success as a women-led/owned business. It’s success is portrayed in this year’s league table, which also saw an increase in successful women-led companies from 28 to 37 countries.

Sunday Times quoted, “Take Dr Rabinder Buttar, founder, CEO and chairman of Clintec. The Glasgow-based clinical research firm develops medicines for seven of the ten largest pharmaceutical companies in the world. It also works with biotech and medical device firms in oncology, rare diseases and other therapeutic areas. Almost all of its sales in 2017 were international, and the company now operates in more than 50 developed and emerging markets… it has consciously focused on organic growth directed by the needs of its clients.”

Dr Rabinder Buttar also commented on the article:
 “I am proud to see Clintec recognised for its fast growth and success and to be listed amongst the top 100 fastest growing mid-market companies in the UK with regards to international sales.  Clintec has a strong leadership team and hugely committed employees based in almost 50 countries globally. Their excellence in clinical research, hard work and dedication is truly acknowledged here. Clintec also has a loyal client base with some including most of the top 10 pharmaceutical companies in the world as well as innovative biotechnology companies. I am very grateful to everyone who has supported us along our 21 year journey showing continuous solid growth of Clintec and look forward to further success.”
About Clintec
Clintec, established by Dr Buttar in 1997, is an innovative, medium-sized global Clinical Research Organization that provides functional service solutions to the biotech, medical device and pharma industries, with a depth of expertise in oncology and rare diseases. Its client base includes four of the top ten life science companies, for one of which, Clintec has worked for over a decade as a Clinical Research Organisation provider and was elevated to a primary global preferred provider status.
Clintec combines the agility and flexibility typical of smaller CROs with the global coverage associated with large CROs. Utilizing Medidata Rave EDC and Veeva Vault eTMF, Clintec delivers global projects with speed, efficiency, and cost-effectiveness.  Clintec personnel are based in over 50 countries including several differentiated emerging markets. Clintec is a two-time winner of the most prestigious UK award, The Queens Award for Enterprise (2011 & 2017). Dr Buttar is also in the running as a Regional finalist for Scotland in the Ernst & Young Entrepreneur of the Year competition in the category of Scale Up Business of the Year 2018.

You might also be interested in…